ATE384120T1 - Metallbindende verbindungen und deren verwendung in zusammensetzungen für zellkulturmedien - Google Patents

Metallbindende verbindungen und deren verwendung in zusammensetzungen für zellkulturmedien

Info

Publication number
ATE384120T1
ATE384120T1 AT00959504T AT00959504T ATE384120T1 AT E384120 T1 ATE384120 T1 AT E384120T1 AT 00959504 T AT00959504 T AT 00959504T AT 00959504 T AT00959504 T AT 00959504T AT E384120 T1 ATE384120 T1 AT E384120T1
Authority
AT
Austria
Prior art keywords
compositions
culture media
cells
added
metal
Prior art date
Application number
AT00959504T
Other languages
English (en)
Inventor
David Epstein
Paul Battista
Dale Gruber
David Judd
Original Assignee
Invitrogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invitrogen Corp filed Critical Invitrogen Corp
Application granted granted Critical
Publication of ATE384120T1 publication Critical patent/ATE384120T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0043Medium free of human- or animal-derived components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/005Protein-free medium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00959504T 1999-08-27 2000-08-28 Metallbindende verbindungen und deren verwendung in zusammensetzungen für zellkulturmedien ATE384120T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15105599P 1999-08-27 1999-08-27

Publications (1)

Publication Number Publication Date
ATE384120T1 true ATE384120T1 (de) 2008-02-15

Family

ID=22537150

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00959504T ATE384120T1 (de) 1999-08-27 2000-08-28 Metallbindende verbindungen und deren verwendung in zusammensetzungen für zellkulturmedien

Country Status (7)

Country Link
EP (1) EP1210410B1 (de)
JP (1) JP4972261B2 (de)
AT (1) ATE384120T1 (de)
AU (1) AU7081500A (de)
CA (1) CA2383460C (de)
DE (1) DE60037819T2 (de)
WO (1) WO2001016294A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096414A1 (en) 2001-03-27 2003-05-22 Invitrogen Corporation Culture medium for cell growth and transfection
FR2836924B1 (fr) * 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
SI1807504T1 (sl) 2004-11-02 2011-05-31 Ares Trading Sa Brezserumski celiäśni kultivacijski medij za celice sesalcev
US8273553B2 (en) 2004-11-02 2012-09-25 Ares Trading S.A. Production of growth hormone in serum-free cell culture medium for mammalian cells
ATE547511T1 (de) 2004-12-23 2012-03-15 Medimmune Llc Nichttumorbildende mdck-zellinie zur vermehrung von viren
EP1870450A1 (de) * 2006-06-21 2007-12-26 DSMIP Assets B.V. Verfahren um E1-immortalisierte HER Zellen zu kultivieren
WO2008105931A2 (en) 2006-09-15 2008-09-04 Medimmune Vaccines, Inc. Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
JP5431361B2 (ja) 2008-01-09 2014-03-05 セルカ ゲーエムベーハー 改善された培養培地添加物及びそれを用いる方法
CN102215865B (zh) 2008-09-24 2013-10-30 米迪缪尼有限公司 病毒纯化方法
KR101617849B1 (ko) 2009-04-09 2016-05-02 첼카 게엠베하 개선된 단일 세포 클로닝 방법
SG185037A1 (en) 2010-04-26 2012-11-29 Novartis Ag Improved cell culture medium
WO2013166339A1 (en) 2012-05-02 2013-11-07 Life Technologies Corporation High yield transient expression in mammalian cells using unique pairing of high density growth and transfection medium and expression enhancers
US10472605B2 (en) 2014-02-14 2019-11-12 National University Of Ireland, Galway Serum-free medium
EP3322813A1 (de) 2015-07-13 2018-05-23 Life Technologies Corporation System und verfahren für verbesserte transiente proteinexpression in cho-zellen
JP6923523B2 (ja) * 2015-12-03 2021-08-18 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung 微生物の検出のための化学的に明らかな培地
EP3778868B1 (de) 2019-08-16 2022-01-26 UGA Biopharma GmbH Zellkulturmedium zur kultivierung von zellen, verfahren zum kultivieren von zellen und verfahren zur expression von mindestens einem rekombinanten protein in einer zellkultur
WO2026036019A1 (en) 2024-08-09 2026-02-12 Life Technologies Corporation Method of producing a recombinant protein in hek-293 cells

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3324235A1 (de) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen Neue komplexbildner, komplexe und komplexsalze
NO162160C (no) * 1987-01-09 1989-11-15 Medi Cult As Serumfritt vekstmedium, samt anvendelse derav.
DE4033419A1 (de) * 1990-10-20 1992-04-23 Wolman Gmbh Dr Polymere stickstoffverbindungen und metall fixierende saeuren enthaltende holzschutzmittel
EP0593539A1 (de) * 1991-06-21 1994-04-27 Novo Nordisk A/S Additiv für kulturmedium auf der basis von eisenchelaten
CZ282939B6 (cs) * 1992-03-04 1997-11-12 Lonza A.G. Mikrobiologický způsob hydroxylace dusíkatých heterocyklických karboxylových kyselin
US5328913A (en) * 1992-12-11 1994-07-12 Duke University Minoxidil analogs as inhibitors of cell proliferation and lysyl hydroxylase
JP3502420B2 (ja) * 1993-01-21 2004-03-02 日本製薬株式会社 動物細胞培養用培地
JPH07123990A (ja) * 1993-11-08 1995-05-16 Cosmo Sogo Kenkyusho:Kk 2,5−ジヒドロキシピリジンの製造方法および2,5−ジヒドロキシピリジンの合成酵素
JP3413294B2 (ja) * 1994-10-07 2003-06-03 財団法人石油産業活性化センター 2,5−ジヒドロキシピリジンの製造法および2,5−ジヒドロキシピリジン生産菌
ATE299135T1 (de) * 1995-09-29 2005-07-15 Novartis Pharma Gmbh Hydroxypyridinone
US6043092A (en) * 1996-03-18 2000-03-28 University Of Pittsburgh Cell culture media for mammalian cells
JPH1014591A (ja) * 1996-07-03 1998-01-20 Mitsubishi Chem Corp 2−ヒドロキシ含窒素6員環化合物の製造方法
JP4543402B2 (ja) * 1996-10-10 2010-09-15 ライフ テクノロジーズ コーポレーション 植物由来栄養素を含む動物細胞培養培地
ES2194968T3 (es) * 1996-11-13 2003-12-01 Procter & Gamble Composiciones acuosas,alcalinas, que contienen blanqueadores de peroxido de hidrogeno.

Also Published As

Publication number Publication date
EP1210410B1 (de) 2008-01-16
DE60037819T2 (de) 2009-01-08
WO2001016294A2 (en) 2001-03-08
CA2383460C (en) 2015-10-13
AU7081500A (en) 2001-03-26
JP4972261B2 (ja) 2012-07-11
EP1210410A2 (de) 2002-06-05
JP2003508046A (ja) 2003-03-04
CA2383460A1 (en) 2001-03-08
DE60037819D1 (de) 2008-03-06
WO2001016294A3 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
ATE384120T1 (de) Metallbindende verbindungen und deren verwendung in zusammensetzungen für zellkulturmedien
DE69431660D1 (de) 2-pyridylmethylen-polyazamacrocyclophosphonsäuren, ihre komplexe und derivate zur verwendung als kontrastmittel
ATE420945T1 (de) Chemisch definiertes medium für kultivierte säugerzellen
MX2007002380A (es) Produccion de polipeptidos.
DE69721329D1 (de) Zusammensetzung zur Verzögerung des Haarwuchses und entsprechende Verwendung
ATE430807T1 (de) Verfahren zur kultivierung von circovirus
DE60031419D1 (de) Zusammensetzungen und verfahren für verbesserte zellkultur
ATE277058T1 (de) Polyazomacrocyclofluoromonoalkylphosphensäure, ihre komplexe zur verwendung als kontrastmittel
TW200615379A (en) Production of α-abeta
GB2432846B (en) Medium and culture of embryonic stem cells
TW200619388A (en) Production of TNFR-lg
ES2173185T3 (es) Empleo de derivados de tetrahidropteridina como inhibidores de la no-sintasa.
BR0210593A (pt) polinucleotìdeos de defensina e métodos de uso
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
SI1644336T1 (sl) Heteroarilne spojine, ki vsebujejo duĺ ik in njihova uporaba pri zviĺ anju endogenega eritropoetina
ATE338458T1 (de) Konservierungs- und lagerungsmedium für biologische materialien
WO2008061208A3 (en) Arylsulfonamide compounds
ATE548391T1 (de) Gefangene bindungsproteine als biosensoren
ATE294813T1 (de) Konjugate von gallensäure mit metallbindenden chelatverbdingungen und die verwendung davon
WO2007087365A3 (en) Detection of glutathionylated proteins
DE69931050D1 (de) Brassica-transformation durch teilchenbeschuss
TR200103046T2 (tr) IL5 aktivitesini düşürmek için yöntem.
DE60025327D1 (de) 6-arylphenanthridine mit pde-iv hemmender wirkung
SI1465927T1 (sl) Protitelesa proti BAG3 za uporabo pri raziskavi, diagnostiki in terapiji bolezni, ki vključujejo celično smrt
FR2846004B1 (fr) Composition pour culture de cellules notamment animales ou de tissus, comprenant du polyethylene glycol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties